LoisEKrahnMD

Psychiatry • Scottsdale, AZ

Addiction, Sleep Medicine

Professor of Psychiatry, Mayo Clinic School of Medicine

Join to view full profile

Dr. Krahn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Krahn's full profile

Already have an account?

Office
13400 E Shea Blvd
Scottsdale, AZ 85259
Phone+1 480-301-8000

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Psychiatry, 1992 - 1993
MedStar Health Georgetown University (D.C.)Residency, Psychiatry, 1989 - 1992
Mayo Clinic College of MedicineClass of 1989
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Consultation-Liaison Psychiatry

Certifications & Licensure

AZ State Medical License 2003 - 2027
MN State Medical License 1992 - 2026
FL State Medical License 1995 - 2025
MD State Medical License 1991 - 1992
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry
American Board of Psychiatry and Neurology Sleep Medicine

Awards, Honors, & Recognition

Top Doctors:Arizona State Castle Connolly, 2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook

Clinical Trials

A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy Start of enrollment: 2019 Sep 21
COMPLETED
PHASE2

Publications & Presentations

PubMed

Characterization and treatment patterns of patients treated with immediate-release sodium oxybate for narcolepsy: A propensity score-matched cohort study.
Melissa C Lipford, Shahir Asfahan, Gajinder Pal Singh, J Layne Moore, Maja Tippmann-Peikert
Journal of Clinical Neuroscience. 2025-03-21
A Survey of People Living with Narcolepsy in the USA: Path to Diagnosis, Quality of Life, and Treatment Landscape from the Patient's Perspective.
Luis E Ortiz, Anne Marie Morse, Lois Krahn, Maggie Lavender, Matthew Horsnell
CNS Drugs. 2025-03-01
Assessing Early Efficacy After Initiation of Once-Nightly Sodium Oxybate (ON-SXB; FT218) in Participants with Narcolepsy Type 1 or 2: A Post Hoc Analysis from the Phas...
Lois Krahn, Asim Roy, John W Winkelman, Anne Marie Morse, Jennifer Gudeman
CNS Drugs. 2025-03-01

Press Mentions

Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their CliniciansMarch 25th, 2025
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their CliniciansMarch 25th, 2025
Updated Protocols Available for Evaluation of Daytime Sleepiness and AlertnessOctober 26th, 2021
Join now to see all